How the settlement works, what I need to do
Abstract Aims/hypothesis Tirzepatide is a novel dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA) currently under review for marketing approval
What the review covers The Post-Authorization Activity Table for Mounjaro indicates the review was started between November 1 and November 30, 2024 [Source: dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00629]
Each mL of Part II contains: calcium chloride dihydrate 3.85 mg, magnesium chloride hexahydrate 5 mg, dextrose 23 mg, glutathione disulfide (oxidized glutathione) 4.6 mg, in water for injection
Drug class and mechanism Tresiba is a basal insulin analog
The Science That Isnt There Real GLP-1 medications (like Ozempic, Wegovy, or Mounjaro) are prescription-only drugs that contain active compounds called GLP-1 receptor agonists